Tichenor
Burl Wayne Tichenor, Avon, IN US
Patent application number | Description | Published |
---|---|---|
20090236167 | Support frame for auxiliary power unit for a motor vehicle - An auxiliary power system for a long-haul truck includes a first frame which has an auxiliary power unit mounted thereon using elastomeric isolation mounts. A second frame is affixed in a stationary position to an exterior surface of a single longitudinal rail of the vehicle frame. There is a pair of spring elements each operable in a vertical direction and having a first end thereof pivotally connected to a respective side member of the first frame and having a second end thereof pivotally connected to a respective side member of the second frame, whereby the first frame is capable of moving in a vertical plane relative to the second frame for isolating the auxiliary power unit from the effects of road shock and vibration. Elastomeric isolation mounts are also provided for controlling downward movement of the first frame. | 09-24-2009 |
Clyde L. Tichenor, Somis, CA US
Patent application number | Description | Published |
---|---|---|
20090113619 | Dual spout-type faucet with controllable conventional-flow and mister-flow rates - A dual spout-type faucet with controllable conventional-flow and mister-flow rates is provided. In a first mode, one or more mister elements, or apertures having mister-like openings, are co-located proximate to a spout outlet, wherein water flow rates to the mister elements (or openings) and spout outlet are both controllable by one or more valve controllers accessible to a user. In a second mode, one or more mister elements, or apertures having mister-like openings, are co-axially located in a spout outlet wherein water flow rates to the mister elements (or openings) and spout outlet are both controllable by one or more valve controllers accessible to a user. In another embodiment the apparatus may be handheld and positionable and equipped to dispense soap or a cleaning solution optionally including attachable scrubbers. | 05-07-2009 |
Clyde L. Tichenor US
Clyde Leroy Tichenor, Somis, CA US
Jason Tichenor, Spring, TX US
Patent application number | Description | Published |
---|---|---|
20090038856 | Injection System And Method - An injection system and method is described. In several exemplary embodiments, the injection system and method may be a part of, and/or used with, a system and method for excavating a subterranean formation. | 02-12-2009 |
Lee A. Tichenor, Temecula, CA US
Patent application number | Description | Published |
---|---|---|
20100109208 | MULTI-SEGMENT TOOL AND METHOD FOR COMPOSITE FORMATION - A multi-segment tool and tooling system for vacuum forming a composite part. A tool can include a first tool having first and second surfaces. A second tool can have an opening positioned on a first tool in a location other than the first surface or the second surface. The first tool and second tool can receive at least a portion of a preform composite. The first tool can have a vacuum barrier attached to the first surface and to the second surface encapsulating the preform composite and the second tool. A tooling system can include a first tool having a core and a base with a core extending upwards from the base. A second tool can be positioned upon the core where the core extends above the second tool. A vacuum barrier sealed to the base and the core can include a composite, the first tool and the second tool. | 05-06-2010 |
20110308723 | Multi-Segment Tool and Method for Composite Formation - A multi-segment tool and tooling system for vacuum forming a composite part. A tool can include a first tool having first and second surfaces. A second tool can have an opening positioned on a first tool in a location other than the first surface or the second surface. The first tool and second tool can receive at least a portion of a preform composite. The first tool can have a vacuum barrier attached to the first surface and to the second surface encapsulating the preform composite and the second tool. A tooling system can include a first tool having a core and a base with a core extending upwards from the base. A second tool can be positioned upon the core where the core extends above the second tool. A vacuum barrier sealed to the base and the core can include a composite, the first tool and the second tool. | 12-22-2011 |
Mark S. Tichenor, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090062294 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 03-05-2009 |
20110230490 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 09-22-2011 |
20110237596 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 09-29-2011 |
20120088741 | ARYL-SUBSTITUTED HETEROCYCLIC UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain aryl-substituted heterocyclic urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). | 04-12-2012 |
20130245022 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 09-19-2013 |
20140066412 | HETEROARYL SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 03-06-2014 |
20140221322 | HETEROARYL SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 08-07-2014 |
20140275029 | 1,2,6-SUBSTITUTED BENZIMIDAZOLES AS FLAP MODULATORS - The present invention relates to compounds of Formula (I), | 09-18-2014 |